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We reviewed clinical and epidemiologic features of 56
human  Capnocytophaga canimorsus isolates submitted
during a 32-year period to California’s Microbial Diseases
Laboratory for identification. An increasing number of iso-
lates identified as C. canimorsus have been submitted
since 1990. Many laboratories still have difficulty correctly
identifying this species. 
D
ogs are the most common household pets in the
United States. Estimates predict that 50% of all
Americans will be bitten in their lifetime by an animal (1)
and that ≈1 million dog bites will occur annually (2).
Capnocytophaga canimorsus is the main human pathogen
associated with dog bites; this organism causes septicemia,
meningitis, endocarditis, and rare ocular infections (3,4).
Persons at increased risk of developing C. canimorsus
infections include patients who have undergone a splenec-
tomy and those who abuse alcohol. We describe a series of
56 isolates submitted to California’s Microbial Diseases
Laboratory (MDL) in a 32-year period with laboratory and
epidemiologic factors associated with these infections.
The Study
MDL is California’s reference laboratory for detecting
and identifying bacterial, parasitic, and fungal infections
of public health importance. Cultures submitted to MDL
come from >500 clinical laboratories through a network of
39 county or city public health laboratories. Isolates for
identification are forwarded to MDL by public health lab-
oratories with standardized forms that include information
on clinical condition or suspected disease, date of onset, a
brief case history, antimicrobial therapy, origin of speci-
men, and laboratory results. In this manner, clinical infor-
mation and patient demographics were obtained and
analyzed for human cases of C. canimorsus infections
identified from 1972 to 2004. 
Confirmatory testing by our laboratory includes a com-
bination of conventional and molecular techniques involv-
ing biochemical tests, fatty acid methyl ester analysis, and
16S rRNA gene sequencing. These procedures have been
described in detail elsewhere (5). Morphologically,
Capnocytophaga spp. appear as gram-negative medium-
to-long rods with tapered or spindle-shaped ends. The
major phenotypic characteristics of C. canimorsus include
positive test results for oxidase, catalase, arginine dihydro-
lase, and o-nitrophenyl-β-D-galactopyranoside and nega-
tive reactions for urease, nitrates, and indole. Fermentation
of glucose, lactose, and maltose is often observed but not
of raffinose and inulin. Growth is often enhanced by the
addition of rabbit serum and incubation in a carbon diox-
ide–enriched environment. 
Sixty C. canimorsus isolates were forwarded to MDL
for identification or confirmation during the 32-year peri-
od (1972–2004), 56 from humans and 4 from animals. The
average number of clinical strains submitted per year was
1.75; the highest number was recorded in 1998 (n = 8). The
average number of isolates from human cases forwarded to
MDL increased from 1990 to 2004, when 2.2–2.5 strains
were submitted each year, roughly a 4-fold increase over
that observed in the 1970s (Figure). 
The characteristics of these 56 patients are listed in the
Table. The average age was 57.5 years (range 4 months to
99 years); 70% of patients were >50 years of age. Male
patients represented 57% of cases. All strains were recov-
ered from adult patients except for 2 blood isolates recov-
ered from 2 infants. One of these infant cases was
previously described (6). More than 60% of patients from
whom C. canimorsus was recovered initially had sepsis, a
combination of septicemia and meningitis, or a fever of
unknown origin. The most commonly reported symptoms
associated with these conditions were fever (85%), diar-
rhea or abdominal pain (21%), vomiting (18%), headache
(18%), confusion (12%), and myalgia or malaise (<10%).
Disseminated intravascular coagulation (DIC) or septic
shock developed in 7 patients (13%) during hospitaliza-
tion. For 6 patients (11%), the admitting diagnosis was cel-
lulitis; in each instance, C. canimorsus was recovered from
the blood but not from wounds. In 55 (98%) of 56 cases,
C. canimorsus was believed to have caused the clinical
syndrome. The singular exception was a 19-year-old
woman with acute pharyngitis; both C. canimorsus and
group A streptococcus were isolated from her oropharynx.
Among patients with known risk factors associated
with C. canimorsus infection, 3 patients were asplenic; no
patients with a history of alcohol abuse were identified,
although complete medical information was not always
available. Other co-existing conditions in these patients
included chronic obstructive pulmonary disease, diabetes
mellitus, cirrhosis, Grave’s disease, hemosiderosis,
Hodgkin lymphoma, and ovarian cancer. For 27 patients,
records on animal exposure were available. In 21 (78%), a
recent history of a dog bite or close contact with dogs or
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onset of symptoms was 3 days (range 1–10 days). 
Complete or partial medical records were available for
30 cases in which the outcome of infection was recorded.
The case-fatality ratio was 33%. Five of the 6 patients with
culture-confirmed meningitis survived. Patient 6, a 56-
year-old truck driver with meningitis, overwhelming sep-
sis, and DIC, died, as did all other persons with C.
canimorsus–associated DIC.
Only one third (32%) of all isolates forwarded to MDL
were submitted with the correct species identification.
Many strains were received as either an unidentified gram-
negative rod or “identification unknown” (55%). In some
instances (≈13%), strains were submitted with incorrect
identifications, such as Streptobacillus  spp., anaerobes,
Legionella spp., or Haemophilus spp. Microbiologists con-
tinue to have difficulty correctly identifying this organism.
From 1998 to the present, only 5 (28%) of 18 C. canimor-
sus strains were correctly identified to genus and species,
a slightly lower percentage from that observed for the
entire study period.
During the 32-year period, the techniques and methods
used by MDLto identify C. canimorsus evolved. Recently,
2 cultures received by MDL were nonviable when isola-
tion techniques were attempted from submitted blood cul-
ture bottles (1 submitted as a gram-negative rod, the other
as Streptobacillus sp.). In both instances, however, C. can-
imorsus was identified as the etiologic agent by poly-
merase chain reaction (PCR) amplification and 16S rRNA
gene sequencing. This sequence-based approach is proving
increasingly useful for identifying slow-growing, fastidi-
ous bacteria, and it can readily differentiate C. canimorsus
and the phenotypically similar C. cynodegmi (7). 
Conclusions
Our report describes the single largest series of C. can-
imorsus isolates (N = 56) reported in the medical literature
and includes cases of infection from before the species was
described (8) and before the first case report by Bobo and
Newton was published (9). C. canimorsus isolates have
been forwarded to MDL with increasing frequency since
1990 (Figure). The increased frequency associated with C.
canimorsus may be related to several underlying factors,
including more pet (dog, cat) owners, greater opportunities
for animal bites (1,2), and enhanced laboratory techniques
to recover this agent from clinical material. However, the
accurate identification of this life-threatening pathogen
continues to be elusive. The ability of commercial bacteri-
al identification systems to accurately identify these organ-
isms is largely unstudied. Clinical laboratories should
consider C. canimorsus in patients with bacterial sepsis
and a recent history of a dog bite or animal exposure and
with the laboratory observation of fastidious, oxidase- and
catalase-positive, gram-negative rods with fusiform shape.
The clinical characteristics and demographics of 55 C.
canimorsus–infected persons closely resembled those
described in several other studies or reviews (3,4,10). Most
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Figure. Capnocytophaga canimorsus cases (1972–2004); numbers
above bars indicate total human cases during the indicated period. patients were men >50 years of age and had either recent-
ly been bitten by a dog or had prolonged contact with dogs.
Septic shock and DIC carried a poor prognosis. The
observed case-fatality ratio (33%) was comparable to that
(30%–31%) found in 2 other surveys (3,4). Five (83%) of
6 patients with laboratory-confirmed meningitis survived
their systemic infections. LeMoal et al. (11) recently sum-
marized the literature on case reports of C. canimorsus
meningitis and found a low death ratio (5%) associated
with 19 central nervous system infections; our report sup-
ports those observations.
A known risk factor for disseminated C. canimorsus
infection is asplenia, although this condition could only be
demonstrated in 3 (10%) of 31 patients for whom partial or
complete medical histories were available. No cases of
alcoholism were identified in this series, although several
previous series have identified 18%–24% of infected
patients with alcoholism as a predisposing factor (3,4).
However, a limitation of the current study was our inabili-
ty to obtain medical histories on a sizeable number of
patients, despite repeated attempts. Lack of such informa-
tion may considerably bias the data presented.
C. canimorsus is a fastidious organism, often difficult
to isolate and identify. Identification of isolates may
require an extended incubation period (days), delaying lab-
oratory reports and indirectly affecting therapy options and
treatment. Many laboratories were unable to presumptive-
ly identify C. canimorsus isolates, commonly reporting
these strains as either gram-negative rods or fastidious
gram-negative bacilli. Reasons for mislabeling may
include lack of familiarity with the organism, lack of
appropriate biochemical tests, or use of commercial iden-
tification systems not designed for identifying fastidious
microorganisms. These facts, coupled with the low correct
identification rate (32%) provided by laboratories in 3
decades of study, suggest that the frequency of C. canimor-
sus infections in the general population may be underesti-
mated, especially if all such generically identified isolates
are not forwarded to reference or public health laboratories
for definitive identification. Our most recent 2 cases in this
study were eventually identified by 16S rRNA gene
sequencing and were inadequately or incorrectly identified
as other microorganisms by the original submitting labora-
tories. These cases would have been missed without a
molecular approach. Since the case-fatality ratio associat-
ed with this infection has remained unchanged, new
approaches need to be developed to provide a more rapid
and specific diagnosis of this zoonotic pathogen. Such
approaches could include 16S rRNA gene sequencing or
PCR assays targeting species-specific genes.
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